Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine

Journal of Hepatology

Volumn 62, Issue 3, 2015, Pages 599-606

  Healy, Marin E ^a   Chow, Jenny D Y ^a   Byrne, Frances L ^a   Breen, David S ^a   Leitinger, Norbert ^a   Li, Chien ^a   Lackner, Carolin ^c   Caldwell, Stephen H ^a,b   Hoehn, Kyle L ^a,b,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CASPASE 3; DIETHYLNITROSAMINE; FAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; PROTEIN P21; PROTEIN P53; SIRTUIN 1; SUGAR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; AUTACOID; CARBOHYDRATE DIET; CARCINOGEN; FAT INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHOLESTEROL LIVER LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FAT CONTENT; FAT INTAKE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER CANCER; LIVER HISTOLOGY; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; NUTRIENT CONTENT; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK FACTOR; SUGAR INTAKE; TUMOR VOLUME; WESTERN BLOTTING; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; CARBOHYDRATE DIET; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; KETOGENIC DIET; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; WESTERN DIET;

ADIPOKINES; ADIPOSITY; ANIMALS; CARCINOGENS; DIET, WESTERN; DIETARY CARBOHYDRATES; DIETARY FATS; DIETHYLNITROSAMINE; FEMALE; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; KETOGENIC DIET; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; TUMOR BURDEN;

EID: 84922956721     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.10.024     Document Type: Article

References (51)

1. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
2. B.Q. Starley, C.J. Calcagno, and S.A. Harrison Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 2010 1820 1832
3. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
4. J.A. Davila, R.O. Morgan, Y. Shaib, K.A. McGlynn, and H.B. El-Serag Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study Gut 54 2005 533 539
5. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
6. L. Wideroff, G. Gridley, L. Mellemkjaer, W.H. Chow, M. Linet, and S. Keehn Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark J Natl Cancer Inst 89 1997 1360 1365
7. S.H. Jee, H. Ohrr, J.W. Sull, J.E. Yun, M. Ji, and J.M. Samet Fasting serum glucose level and cancer risk in Korean men and women JAMA 293 2005 194 202
8. M. Rossi, L. Lipworth, L.D. Maso, R. Talamini, M. Montella, and J. Polesel Dietary glycemic load and hepatocellular carcinoma with or without chronic hepatitis infection Ann Oncol 20 2009 1736 1740
9. L. Verna, J. Whysner, and G.M. Williams N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation Pharmacol Ther 71 1996 57 81
10. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 2006 674 687
11. F. Heindryckx, I. Colle, and H. Van Vlierberghe Experimental mouse models for hepatocellular carcinoma research Int J Exp Pathol 90 2009 367 386
12. N. Turner, K. Hariharan, J. TidAng, G. Frangioudakis, S.M. Beale, and L.E. Wright Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids Diabetes 58 2009 2547 2554
13. M. Evert, D.F. Calvisi, K. Evert, V. De Murtas, G. Gasparetti, and S. Mattu AKT/mTOR activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis Hepatology 55 2012 1473 1484
14. D.F. Calvisi, C. Wang, C. Ho, S. Ladu, S.A. Lee, and S. Mattu Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma Gastroenterology 140 2011 e1075
15. Y. Nagai, S. Yonemitsu, D.M. Erion, T. Iwasaki, R. Stark, and D. Weismann The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance Cell Metab 9 2009 252 264
16. C. Messier, K. Whately, J. Liang, L. Du, and D. Puissant The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL/6 mice Behav Brain Res 178 2007 139 145
17. J.R. Garbow, J.M. Doherty, R.C. Schugar, S. Travers, M.L. Weber, and A.E. Wentz Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet Am J Physiol Gastrointest Liver Physiol 300 2011 G956 G967
18. H.C. Freeman, A. Hugill, N.T. Dear, F.M. Ashcroft, and R.D. Cox Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice Diabetes 55 2006 2153 2156
19. S.D. Vesselinovitch, and N. Mihailovich Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse Cancer Res 43 1983 4253 4259
20. K.L. Hoehn, N. Turner, M.M. Swarbrick, D. Wilks, E. Preston, and Y. Phua Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity Cell Metab 11 2010 70 76
21. E.P. Taddeo, R.C. Laker, D.S. Breen, Y.N. Akhtar, B.M. Kenwood, and J.A. Liao Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle Mol Metab 3 2014 124 134
22. E.D. Berglund, C.Y. Li, G. Poffenberger, J.E. Ayala, P.T. Fueger, and S.E. Willis Glucose metabolism in vivo in four commonly used inbred mouse strains Diabetes 57 2008 1790 1799
23. J.D. Chow, R.T. Lawrence, M.E. Healy, J.E. Dominy, J.A. Liao, and D.S. Breen Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation Mol Metab 3 2014 419 431
24. J. Folch, M. Lees, and G.H. Sloane Stanley A simple method for the isolation and purification of total lipides from animal tissues J Biol Chem 226 1957 497 509
25. C. Cao, S. Lu, R. Kivlin, B. Wallin, E. Card, and A. Bagdasarian AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes J Biol Chem 283 2008 28897 28908
26. G. He, Y.W. Zhang, J.H. Lee, S.X. Zeng, Y.V. Wang, and Z. Luo AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity Mol Cell Biol 34 2014 148 157
27. J. Luo, A.Y. Nikolaev, S. Imai, D. Chen, F. Su, and A. Shiloh Negative control of p53 by Sir2alpha promotes cell survival under stress Cell 107 2001 137 148
28. G. Leandro, A. Mangia, J. Hui, P. Fabris, L. Rubbia-Brandt, and G. Colloredo Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
29. S.H. Caldwell, D.M. Crespo, H.S. Kang, and A.M. Al-Osaimi Obesity and hepatocellular carcinoma Gastroenterology 127 2004 S97 S103
30. J.M. Regimbeau, M. Colombat, P. Mognol, F. Durand, E. Abdalla, and C. Degott Obesity and diabetes as a risk factor for hepatocellular carcinoma Liver Transpl 10 2004 S69 S73
31. I.R. Wanless, and J.S. Lentz Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106 1110
32. W. Juakiem, D.M. Torres, and S.A. Harrison Nutrition in cirrhosis and chronic liver disease Clin Liver Dis 18 2014 179 190
33. M. Montella, A. Crispo, and A. Giudice HCC, diet and metabolic factors: diet and HCC Hepat Mon 11 2011 159 162
34. D.S. Mandair, R.E. Rossi, M. Pericleous, T. Whyand, and M. Caplin The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma Expert Rev Gastroenterol Hepatol 8 2014 369 382
35. E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, and R.G. Holzer Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140 2010 197 208
36. A.E. Hill-Baskin, M.M. Markiewski, D.A. Buchner, H. Shao, D. DeSantis, and G. Hsiao Diet-induced hepatocellular carcinoma in genetically predisposed mice Hum Mol Genet 18 2009 2975 2988
37. M. Kahle, M. Horsch, B. Fridrich, A. Seelig, J. Schultheiss, and J. Leonhardt Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis Mol Metab 2 2013 435 446
38. A. Nicholson, P.C. Reifsnyder, R.D. Malcolm, C.A. Lucas, G.R. MacGregor, and W. Zhang Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene Obesity (Silver Spring) 18 2010 1902 1905
39. H. Nordenstedt, D.L. White, and H.B. El-Serag The changing pattern of epidemiology in hepatocellular carcinoma Dig Liver Dis 42 2010 S206 S214
40. A. Misra, N. Singhal, and L. Khurana Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils J Am Coll Nutr 29 2010 289S 301S
41. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
42. M.S. Ascha, I.A. Hanouneh, R. Lopez, T.A. Tamimi, A.F. Feldstein, and N.N. Zein The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 2010 1972 1978
43. Y. Zen, K. Katayanagi, K. Tsuneyama, K. Harada, I. Araki, and Y. Nakanuma Hepatocellular carcinoma arising in non-alcoholic steatohepatitis Pathol Int 51 2001 127 131
44. E.P. Brass, and W.H. Vetter Stimulation of lipogenesis by interleukin-6 and misoprostol-free acid in isolated rat hepatocytes Am J Ther 2 1995 706 710
45. L.P. Bechmann, R.A. Hannivoort, G. Gerken, G.S. Hotamisligil, M. Trauner, and A. Canbay The interaction of hepatic lipid and glucose metabolism in liver diseases J Hepatol 56 2012 952 964
46. E. Rysman, K. Brusselmans, K. Scheys, L. Timmermans, R. Derua, and S. Munck De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation Cancer Res 70 2010 8117 8126
47. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 7 2007 763 777
48. K. Aleksandrova, H. Boeing, U. Nothlings, M. Jenab, V. Fedirko, and R. Kaaks Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer Hepatology 60 2014 858 871
49. N.K. Saxena, P.P. Fu, A. Nagalingam, J. Wang, J. Handy, and C. Cohen Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma Gastroenterology 139 2010 1762 1773 1773, e1761-e1765
50. J. Ran, T. Hirano, T. Fukui, K. Saito, H. Kageyama, and K. Okada Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance Metabolism 55 2006 478 488
51. R. Rezvani, K. Cianflone, J.P. McGahan, L. Berglund, A.A. Bremer, and N.L. Keim Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes Obesity 21 2013 2471 2480